| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.00097 | 1 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.0009 | 1 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.00093 | 1 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.0008 | 1 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.00091 | 1 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.0007 | 1 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.00057 | 1 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00044 | 1 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.00038 | 1 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.00024 | 1 |